haylaavo

PLETHICO

PLETHICO · NSE · inactive
9.05
-0.45 (-4.74%)
as of 13 Jun 2016 close
Open
9.05
High
9.05
Low
9.05
Prev close
9.50
52w high
36.70
03 Aug 2015
52w low
9.05
13 Jun 2016
VWAP
9.05
Delivery %
—
n/a
Volume 200 · turnover ₹1,810 · NSE bhavcopy (official close) · history since 05 May 2006
Series
BZ
F&O
No
Status
Inactive since 05 Apr 2016

Source: NSE equity master · as of 04 Apr 2016

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 01:25 IST
  • 10 May 2016 16:16
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that the Company has received a resignation letter from the Director Ms Meena Matani.

    PDF · -
  • 05 Feb 2016 17:55
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange regarding appointment and resignation of Whole Time Director and Reconstitution of the Committee.

    PDF · -
  • 11 Oct 2013 17:48
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that : (a) Mr. Amrish Kumar Chourasia, Company Secretary, ceased to be the Company Secretary of the Company, w.e.f. September 27, 2013, consequent to his resignation dated July 29, 2013; (b) Ms. Khushboo Kothari is appointed as the Company Secretary of the Company, w.e.f. September 27, 2013. Further, Ms. Khushboo Kothari, Company Secretary is appointed as the Compliance Officer of the Company, w.e.f. September 27, 2013.

  • 05 Feb 2010 16:56
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that Mr. Amrish Kumar Chourasia has been appointed as the "Company Secretary' and "Compliance Officer" of the Company w.e.f. January 27, 2010 in place of Mr. Ashok Mishra, Company Secretary who has resigned from the Company w.e.f, January 27, 2010.

  • 28 Mar 2008 15:24
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that "The Board of Directors of the Company at its meeting held on March 28, 2008 has approved the following: 1) Re-appointment of Shri Shashikant Patel and Shri Chirag Patel as Chairman & Managing Director and Whole-time Director & Chief Executive Officer of the Company respectively for a further period of 3 years w.e.f. 01.04.2008 at a remuneration as may be decided by the Board of Directors within the limits prescribed under Schedule XIII of the Companies Act, 1956 and subject to approval of members of the Company at the General Mee

  • 19 Feb 2008 15:22
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that "Mr. Ashok Mishra has been appointed as the "Company Secretary" and "Compliance Officer" of the Company w.e.f. 16/02/2008 in place of Mr. Pankaj Pabaiya, who has resigned from the Company w.e.f. 16/02/2008".

  • 23 Nov 2007 16:58
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that: "Mr. Ashok Sodhani, Non Executive Independent Director of the Company resigned from the Board of Directors of the Company with effect from 22nd November, 2007."

  • 05 Jan 2007 11:41
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that a meeting of the Board of Directors of the company was held on 28th December, 2006 and following major business were transacted during the course of such meeting - Noting of acceptance of resignation of Mr. Rakesh Jain from the Board of Director of the Company w.e.f 05th December, 2006.

  • 29 Nov 2006 15:05
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the company in its meeting held on November 29, 2006 at the Administrative office of the Company appointed Mr. Pramod Kishore Shrivastava and Mr. Abhay Suhane as Additional Directors of the Company to hold office upto the date of next Annual General Meeting. Mr. Sanjay Gupta, Additional Director of the Company resigned from the board w.e.f. November 29, 2006.

  • 02 Nov 2006 16:08
    Management

    Plethico Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company in its meeting held on November 02,2006, appointed Dr. Gulam Nabi Qazi as an Additional Director of the Company.

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries